9101621

10 known cases. View patent page →

Cases
10
Active
1
9 closed
Filed
2016–2021
Top venue
D. New Jersey
5 cases

Filing activity

2016: 1 case'162017: 2 cases2'17'182019: 2 cases'192020: 1 case'202021: 1 case'21
Cases asserting US Patent 9101621 filed per year.

Celgene Corporation v. Zydus Pharmaceuticals (USA) Inc. et al.

settled
Docket:
2:17-cv-02528
Filed:
2017-04-12
Terminated:
2021-03-24

Celgene sued Zydus/Cadila/Zydus International for patent infringement under 35 U.S.C. § 271(e)(2) in D.N.J. The case asserted multiple lenalidomide patents including 8,648,095. Consent judgment entered 2021-03-24 dismissing with prejudice pursuant to settlement.

Celgene Corporation v. Dr. Reddy's Laboratories, Ltd. et al.

settled
Docket:
2:16-cv-07704
Filed:
2016-10-20
Terminated:
2020-09-17

Patent infringement action involving ANDA No. 209348; complaint expressly alleged infringement of the '800, '217, '569, '498, '095, '621 and '622 patents. Settled September 17, 2020 with volume-limited license from September 1, 2022 and unlimited from January 31, 2026.

Blue Cross Blue Shield Association plaintiffs v. Celgene Corporation et al.

Antitrust action by Blue Cross Blue Shield Association plaintiffs against Celgene/BMS concerning Revlimid settlements; patents cited include the same Revlimid patent set as the In re Revlimid litigation.

Celgene Corporation v. Lotus Pharmaceutical Co., Ltd. et al.

settled/consent judgment
Docket:
2:17-cv-06842
Filed:
2017-09-06
Terminated:
2019-03-29
Patents:9101621

Celgene sued Lotus and Alvogen in D.N.J. over generic lenalidomide. The case resolved by consent judgment on March 29, 2019, with the '621 patent expressly among the patents-in-suit and an injunction barring generic launch until expiry except as licensed.

Celgene Corporation v. Cipla Ltd. et al.

settled/consent judgment
Filed:
2019-07-03
Terminated:
2020-12-14

Celgene sued Cipla and a Cipla USA affiliate in D.N.J. over generic lenalidomide. The asserted patents included '800, '217, '569, '498, '095, '621, '622, '740, '717, and '120; a stipulated consent judgment was entered December 14, 2020. The case number was not confirmed in the sources.